Cargando…

Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.

A prospective study was performed to assess the use of plasma measurement of tumour necrosis factor (TNF), lymphotoxin alpha (LT alpha) and their soluble receptors (p55 and p75) for prognostic risk assignment in 61 patients with Hodgkin's disease. Plasma levels of TNF, p55 and p75, but not of L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warzocha, K., Bienvenu, J., Ribeiro, P., Moullet, I., Dumontet, C., Neidhardt-Berard, E. M., Coiffier, B., Salles, G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150385/ https://www.ncbi.nlm.nih.gov/pubmed/9649158

Ejemplares similares

The influence of 2- chlorodeoxyadenosine in combination with tumour necrosis factor-α or its mutein on murine leukaemias L1210 and P388
por: Góra-Tybor, J., et al.
Publicado: (1995)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2012)

Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2.
por: Miles, D. W., et al.
Publicado: (1992)

Soluble tumour necrosis factor receptor type II and survival in colorectal cancer
por: Babic, Ana, et al.
Publicado: (2016)

A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-α and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice
por: Warzocha, K., et al.
Publicado: (1994)

Resources-Stratified Guidelines for Classical Hodgkin Lymphoma
por: Relecom, Allan, et al.
Publicado: (2020)

Tumour necrosis factor-alpha, interleukin-2 soluble receptor and different inflammatory parameters in patients with rheumatoid arthritis.
por: Fröde, Tânia Silvia, et al.
Publicado: (2002)

Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.
por: Pizzolo, G., et al.
Publicado: (1987)

Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes
por: Neidhardt-Berard, Eve-Marie, et al.
Publicado: (2004)

Clinical Features of Acute Coronary Syndrome in Patients with Coronary Heart Disease and Its Correlation with Tumour Necrosis Factor in Cardiology
por: Guo, Run, et al.
Publicado: (2022)

Association of soluble interleukin‐2 receptor α and tumour necrosis factor receptor 1 with heart failure: The Multi‐Ethnic Study of Atherosclerosis
por: Bakhshi, Hooman, et al.
Publicado: (2020)

Factors affecting the concentration of soluble tumour necrosis factor-α receptor type I in the blood serum of patients with localized scleroderma
por: Zbiciak-Nylec, Martyna, et al.
Publicado: (2020)

Colorectal cancer severity and survival in correlation with tumour necrosis factor-alpha
por: Stanilov, Noyko, et al.
Publicado: (2014)

Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CT
por: Rossi, Cédric, et al.
Publicado: (2017)

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors
Publicado: (1992)

Plasma levels of soluble tumor necrosis factor-α receptors are related to total and LDL-cholesterol in lean, but not in obese subjects
por: Straczkowski, Marek, et al.
Publicado: (2006)

Progressive growth of human papillomavirus type 16-transformed keratinocytes is associated with an increased release of soluble tumour necrosis factor (TNF) receptor.
por: Malejczyk, J., et al.
Publicado: (1996)

Soluble tumour necrosis factor receptor I is a promising early indicator of complicated clinical outcome in patients following severe trauma
por: BINKOWSKA, ANETA M., et al.
Publicado: (2020)

Soluble receptors of tumor necrosis factor-α: early predictors of mortality in patients with severe burn injury
por: Ribeiro, CA, et al.
Publicado: (2001)

Role of soluble gp130 in the tumour necrosis factor-alpha expression and its production by peripheral blood mononuclear cells.
por: Jablonskaca, E, et al.
Publicado: (2003)

Serial measurement of the circulating levels of tumour necrosis factor and its soluble receptors 1 and 2 for monitoring leprosy patients during multidrug treatment
por: Costa, Rosane Dias, et al.
Publicado: (2013)

Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies
por: Holst-Hansen, C, et al.
Publicado: (1999)

Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor.
por: Trentin, L., et al.
Publicado: (1995)

Plasma tumour necrosis factor‐alpha‐related proteins in prognosis of heart failure with pulmonary hypertension
por: Engel Sällberg, Adam, et al.
Publicado: (2023)

The effect of capsaicin on circulating biomarkers, soluble tumor necrosis factor and soluble tumor necrosis factor-receptor-1 and -2 levels in vivo using lipopolysaccharide-treated mice
por: Ijiri, Yoshio, et al.
Publicado: (2014)

Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients
por: Liu, Xin-ran, et al.
Publicado: (2023)

Evaluation of Tumour Necrosis Factor Alpha, Interleukin-2 Soluble Receptor, Nitric Oxide Metabolites, and Lipids as Inflammatory Markers in Type 2 Diabetes Mellitus
por: Pereira, Flávia Ozorio, et al.
Publicado: (2006)

The Role of Costimulatory Receptors of the Tumour Necrosis Factor Receptor Family in Atherosclerosis
por: Antunes, Ricardo F., et al.
Publicado: (2012)

The Relationship of Fever to Tumour Necrosis in the Rat
por: Allen, Ingrid V.
Publicado: (1964)

Early effects of tumor necrosis factor inhibition on bone homeostasis after soluble tumor necrosis factor receptor use
por: Lim, Mie Jin, et al.
Publicado: (2014)

Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis
por: Yang, Nicole, et al.
Publicado: (2019)

Long-Term Response and Remission with Pixantrone in Patients with Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma: Post-Hoc Analysis of the Multicenter, Open-Label, Randomized PIX301 Trial
por: Pettengell, Ruth, et al.
Publicado: (2018)

Plasma Soluble Urokinase Receptor Level Is Correlated with Podocytes Damage in Patients with IgA Nephropathy
por: Zhao, Yanfeng, et al.
Publicado: (2015)

Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) Are Associated with Hippocampal Volume and Cognitive Performance in Patients with Schizophrenia
por: Kudo, Noriko, et al.
Publicado: (2018)

Starch Electrophoresis of Soluble Tumour Proteins
por: Pantelouris, E. M.
Publicado: (1963)

Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast.
por: Pusztai, L., et al.
Publicado: (1994)

Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
por: Viviani, S., et al.
Publicado: (1998)

Serum soluble toll-like receptor 2 and 4 as diagnostic and prognostic biomarkers for non-Hodgkin lymphoma
por: Fakhry, Nouran, et al.
Publicado: (2020)

Carnitine and congeners as regulators of tumour necrosis factor
por: De Simone, Claudio, et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_qg0ev4adc27823nds0rpq0grec